awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33593865-0EA09E4A-558C-4CEC-8EFF-B8A544690A72
Q33593865-0EA09E4A-558C-4CEC-8EFF-B8A544690A72
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33593865-0EA09E4A-558C-4CEC-8EFF-B8A544690A72
Immunotherapy in hematologic malignancies: past, present, and future.
P2860
Q33593865-0EA09E4A-558C-4CEC-8EFF-B8A544690A72
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33593865-0EA09E4A-558C-4CEC-8EFF-B8A544690A72
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
26b2f2667e7101b1e4ac13c9ab0082278ed0aefd
P2860
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.